產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-ELOVL4抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-ELOVL4抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ELOVL4
Cat. Number:
Anti-ELOVL4抗體KL-14572R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a membrane-bound protein which is a member of the ELO family, proteins which participate in the biosynthesis of fatty acids. Consistent with the expression of the encoded protein in photoreceptor cells of the retina, mutations and small deletions in this gene are associated with Stargardt-like macular dystrophy Anti-ELOVL4抗體(STGD3) and autosomal dominant Stargardt-like macular dystrophy (ADMD), also referred to as autosomal dominant atrophic macular degeneration. [provided by RefSeq, Jul 2008]
Also known as:
3-keto acyl-CoA synthase ELOVL4; ADMD; Cancer/testis antigen 118; CT118; Elongation of very long chain fatty acids (FEN1/Elo2 SUR4/Elo3 yeast) like 4; elongation of very long chain fatty acids (FEN1/Elo2 SUR4/Elo3 yeast)-like 4;Anti-ELOVL4抗體 Elongation of very long chain fatty acids like 4; Elongation of very long chain fatty acids protein 4; ELOV L4; ELOV4_HUMAN; ELOVL 4; ELOVL4; FLJ17667; FLJ92876; Stargardt disease 3; Stargardt disease 3 autosomal dominant; STGD 2; STGD 3; STGD2; STGD3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Anti-ELOVL4抗體Rat, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ELOVL4.
●
Predicted Molecular Weight: 37kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-ELOVL4抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-ELOVL4抗體
Optimal working dilutions must be determined by the end user.
kl081Hu01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl081Mu01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl081Ra01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl081Si01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl083Hu01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Mu01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Po01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Ra01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl085Bo01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Ca01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Cp01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Hu01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Mu01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Po01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Ra01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl086Bo01 L選擇素(SELL)多克隆抗體 Polyclonal Antibody to Selectin, Leukocyte (SELL)
kl086Hu01 L選擇素(SELL)多克隆抗體 Polyclonal Antibody to Selectin, Leukocyte (SELL)
kl086Mu01 L選擇素(SELL)多克隆抗體 Polyclonal Antibody to Selectin, Leukocyte (SELL)
